Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-cash Items (2016 - 2025)

Bio-Techne has reported Non-cash Items over the past 13 years, most recently at $7.1 million for Q2 2025.

  • Quarterly results put Non-cash Items at $7.1 million for Q2 2025, down 13.1% from a year ago — trailing twelve months through Jun 2025 was $7.1 million (down 13.1% YoY), and the annual figure for FY2025 was $7.1 million, down 13.1%.
  • Non-cash Items for Q2 2025 was $7.1 million at Bio-Techne, down from $8.2 million in the prior quarter.
  • Over the last five years, Non-cash Items for TECH hit a ceiling of $8.6 million in Q2 2023 and a floor of $7.1 million in Q2 2021.
  • Median Non-cash Items over the past 5 years was $7.8 million (2022), compared with a mean of $7.8 million.
  • Biggest five-year swings in Non-cash Items: surged 351.21% in 2021 and later dropped 13.1% in 2025.
  • Bio-Techne's Non-cash Items stood at $7.1 million in 2021, then increased by 10.49% to $7.8 million in 2022, then rose by 10.82% to $8.6 million in 2023, then dropped by 5.01% to $8.2 million in 2024, then dropped by 13.1% to $7.1 million in 2025.
  • The last three reported values for Non-cash Items were $7.1 million (Q2 2025), $8.2 million (Q2 2024), and $8.6 million (Q2 2023) per Business Quant data.